Surpassing conventional therapies: The role of biologic therapy

被引：4

作者：

Baldassano, RN ^{[1
]}

机构：

[1] Childrens Hosp Philadelphia, Ctr Pediat Inflammatory Bowel Dis, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA

来源：

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2001年 / 33卷

关键词：

D O I：

10.1097/00005176-200109001-00004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S19 / S26

页数：8

共 27 条

[1]

Baldassano R, 1999, GASTROENTEROLOGY, V116, pA665

[2] TUMOR-NECROSIS-FACTOR-ALPHA IN STOOL AS A MARKER OF INTESTINAL INFLAMMATION [J].

BRAEGGER, CP ;

NICHOLLS, S ;

MURCH, SH ;

STEPHENS, S ;

MACDONALD, TT .

LANCET, 1992, 339 (8785) :89-91

[3] Etanercept (TNF receptor fusion protein, Enbrel®) is effective and well tolerated in active refractory Crohn's disease:: Results of a single center pilot trial. [J].

D'Haens, G ;

Swijsen, C ;

Noman, M ;

Lemmens, L ;

Geboes, K ;

Rutgeerts, P .

GASTROENTEROLOGY, 2000, 118 (04) :A656-A656

[4] Interleukin-11: Review of molecular, cell biology, and clinical use [J].

Du, XX ;

Williams, DA .

BLOOD, 1997, 89 (11) :3897-3908

[5] A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human antibody to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease. [J].

Feagan, BG ;

Sandborn, WJ ;

Baker, JP ;

Cominelli, F ;

Sutherland, LR ;

Elson, CD ;

Salzberg, B ;

Archambault, A ;

Bernstein, CN ;

Lichtenstein, GR ;

Heath, PK ;

Hanauer, SB .

GASTROENTEROLOGY, 2000, 118 (04) :A655-A655

[6] Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease [J].

Fedorak, RN ;

Gangl, A ;

Elson, CO ;

Rutgeerts, P ;

Schreiber, S ;

Wild, G ;

Hanauer, SB ;

Kilian, A ;

Cohard, M ;

LeBeaut, A ;

Feagan, B .

GASTROENTEROLOGY, 2000, 119 (06) :1473-1482

[7] Use of infliximab in the treatment of Crohn's disease in children and adolescents [J].

Hyams, JS ;

Markowitz, J ;

Wyllie, R .

JOURNAL OF PEDIATRICS, 2000, 137 (02) :192-196

[8] CONSTRUCTION AND INITIAL CHARACTERIZATION OF A MOUSE-HUMAN CHIMERIC ANTI-TNF ANTIBODY [J].

KNIGHT, DM ;

TRINH, H ;

LE, JM ;

SIEGEL, S ;

SHEALY, D ;

MCDONOUGH, M ;

SCALLON, B ;

MOORE, MA ;

VILCEK, J ;

DADDONA, P ;

GHRAYEB, J .

MOLECULAR IMMUNOLOGY, 1993, 30 (16) :1443-1453

[9] Message therapy: Gene therapy that targets mRNA sequence and stability [J].

Kozarsky, KF ;

Couture, LA .

AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) :790-794

[10]

Kugathasan S, 2000, AM J GASTROENTEROL, V95, P3189

← 1 2 3 →